MHLW Restarts Discussions Over Intractable Diseases, Hopes For Law Reforms Proposals By November
This article was originally published in PharmAsia News
The MHLW Japan Committee on Measures against Intractable Diseases met for the first time in seven months on Sept. 3, reopening discussions concerning law reform proposals concerning intractable diseases.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.